Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety

Anxiety disorders are the most common mental illness in the U.S. and are estimated to consume one-third of the country’s mental health spending. Although anxiolytic therapies are available, many patients exhibit treatment-resistance, relapse, or substantial side effects. An urgent need exists to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Joshua, Shao, Amy S., Shen, Yi, Davies, Daryl L., Olsen, Richard W., Holschneider, Daniel P., Shao, Xuesi M., Liang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364153/
https://www.ncbi.nlm.nih.gov/pubmed/32742262
http://dx.doi.org/10.3389/fphar.2020.01008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364153/
https://www.ncbi.nlm.nih.gov/pubmed/32742262
http://dx.doi.org/10.3389/fphar.2020.01008

Ejemplares similares